Menopause Market Size, Share & Trends Analysis Report By Treatment (Dietary Supplements, OTC Pharma Products), By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2021 - 2028

Report Overview

The global menopause market size was valued at USD 14.7 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 5.7% from 2021 to 2028. The high prevalence of vasomotor and other menopausal symptoms and increasing research supporting the advantages of dietary supplements is expected to drive the growth of the market.

Night sweats and hot flashes or Vasomotor Symptoms (VMS) are key symptoms of Menopausal Transition (MT). In addition, issues such as mood swings, difficulty in concentrating, and depression are also being linked to menopause. Hot flashes are experienced by around 80% of women during menopause and are characterized by transient chills, anxiety, sweating, and sensations of heat that last for around 1-5 minutes. Although hot flashes are experienced by a large number of women, other symptoms are also experienced by a considerable number, viz. weight gain, mood disorders, insomnia, night sweats, and vaginal dryness.

Menopausal Hormone Therapy (MHT), also called hormone replacement therapy and postmenopausal hormone therapy is recommended to help relieve symptoms of menopause. However, there may be adverse effects, such as vaginal bleeding, hip & vertebral fractures, dementia, urinary incontinence, breast cancer, heart attack, blood clots, stroke, and colorectal cancer. The awareness about adverse effects and risks associated with MHT might increase the adoption of supplements by menopausal women.

The COVID-19 pandemic has negatively impacted individual health. The high amount of stress and mental health problems, along with hormonal imbalance, have resulted in increasingly adverse menopausal symptoms. The pandemic and resulting lockdown restrictions have led to growing awareness about health and the role that products such as dietary supplements play in promoting health, including regulating menopausal symptoms. In August 2020, according to the results of a study conducted by the Council for Responsible Nutrition (CRN), a trade association for the functional food and dietary supplement industry, dietary supplement usage increased during the pandemic.

Treatment Insights

The dietary supplements segment dominated the menopause market and accounted for a revenue share of more than 90.0% in 2020. The segment is expected to dominate the market over the forecast period. The segment is further classified into hormonal products and non-hormonal products.

Dietary supplements are used by women to help ease the symptoms of menopause, such as hot flashes, night sweats, mood swings, and insomnia. In addition, research has shown the role of dietary supplements in the prevention of early menopause. A study published by the American Journal of Clinical Nutrition in June 2017, evaluated the effect of calcium and vitamin D from supplements and foods on women. The study revealed that a high intake of dietary calcium and vitamin D lowered the risk of early menopause.

Regional Insights

North America dominated the market and accounted for the largest revenue share of 35.0% in 2020 owing to a high prevalence of menopausal symptoms such as hot flashes, and high healthcare expenditure. However, in Latin America, the market is expected to witness the fastest growth over the forecast period owing to key factors such as increasing awareness about women’s health.

As the millennial population is aging, the U.S. has a large number of women entering menopause; around 6,000 women are expected to enter menopause each day in the U.S. According to a menopause survey conducted by AARP, a U.S.-based nonprofit organization, for its female members between 60 years to 69 years of age around 72% of women, revealed that menopausal symptoms affected their lives and 8% of them admitted the effects to be extreme. The average age of undergoing menopause transition is early in the Latin America region, as compared to western nations. Although the prevalence of menopausal symptoms such as hot flashes is moderate in the region, the change in lifestyle and food habits is contributing to the growing adoption of dietary supplements for menopause to meet nutritional requirements.

Key Companies & Market Share Insights

The market is fragmented with the presence of various global and regional manufacturers. Mergers and acquisitions and expansion of product portfolios are the key strategic undertakings of these companies to increase market share. In March 2018, Teva Pharmaceuticals announced the launch of generic, Estrace Cream, for the treatment of menopausal symptoms such as vaginal and vulvar atrophy. Some of the prominent players in the menopause market include:

• Bayer AG

• Theramex

• Teva Pharmaceutical Industries Ltd.

• AbbVie, Inc.

• Abbott

• Pure Encapsulations, LLC.

• Dr. Reddy’s Laboratories Ltd.

Menopause Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global menopause market report on the basis of treatment and region:

• Treatment Outlook (Revenue, USD Million, 2016 - 2028)

  • Dietary Supplements

  • OTC Pharma Products

    • Hormonal products

    • Non-hormonal products

• Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • Spain

    • France

    • Italy

    • Austria

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

  • Latin America

    • Brazil

    • Mexico

  • Middle East & Africa (MEA)

    • South Africa